Legal Representation
Attorney
Erich G. Rhynhart
USPTO Deadlines
Next Deadline
166 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
April 22, 2026
Extension Available
Until October 22, 2025
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 24, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 24, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 24, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 5, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 5, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 4, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 27, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 22, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 22, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 22, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 22, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 22, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 17, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 18, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 3, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Providing a website and online portal featuring aggregated pharmaceutical and medical claims data for market research purposes; Providing a website and online portal featuring aggregated Medicare claims data, competitive market share data, claims documents and invoices for pharmaceutical manufacturer market research
Class 042
Providing a website and online portal featuring aggregated pharmaceutical and medical claims data for medical and scientific research; Providing a website featuring technology that enables users to view aggregated Medicare claims data, competitive market share data and to share claims documents and invoices with pharmaceutical manufacturers
Additional Information
Pseudo Mark
MEDICARE ANALYTICS AND INSIGHTS EDGE
Classification
International Classes
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICARE ANALYTICS"